Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease.
Identifieur interne : 001610 ( Main/Exploration ); précédent : 001609; suivant : 001611Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease.
Auteurs : V. Marchand-Pauvert [France] ; A. Gerdelat-Mas ; F. Ory-Magne ; F. Calvas ; D. Mazevet ; S. Meunier ; C. Brefel-Courbon ; M. Vidailhet ; M. Simonetta-MoreauSource :
- Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology [ 1872-8952 ] ; 2011.
English descriptors
- KwdEn :
- Adult, Aged, Analysis of Variance, Antiparkinson Agents (pharmacology), Antiparkinson Agents (therapeutic use), Deep Brain Stimulation, Electromyography, Female, Humans, Levodopa (pharmacology), Levodopa (therapeutic use), Male, Middle Aged, Muscle Rigidity (therapy), Parkinson Disease (physiopathology), Parkinson Disease (therapy), Reflex (drug effects), Reflex (physiology).
- MESH :
- chemical , pharmacology : Antiparkinson Agents, Levodopa.
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- drug effects : Reflex.
- physiology : Reflex.
- physiopathology : Parkinson Disease.
- therapy : Muscle Rigidity, Parkinson Disease.
- Adult, Aged, Analysis of Variance, Deep Brain Stimulation, Electromyography, Female, Humans, Male, Middle Aged.
Abstract
To investigate the contribution of group II spinal pathways in Parkinsonian upper limb rigidity and the modulation of spinal excitability of group I and group II pathways by L-DOPA and subthalamic nucleus-high-frequency stimulation (STN-HFS).
DOI: 10.1016/j.clinph.2010.08.015
PubMed: 20943434
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000977
- to stream PubMed, to step Curation: 000937
- to stream PubMed, to step Checkpoint: 000937
- to stream Ncbi, to step Merge: 000C31
- to stream Ncbi, to step Curation: 000C31
- to stream Ncbi, to step Checkpoint: 000C31
- to stream Main, to step Merge: 001691
- to stream Main, to step Curation: 001610
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease.</title>
<author><name sortKey="Marchand Pauvert, V" sort="Marchand Pauvert, V" uniqKey="Marchand Pauvert V" first="V" last="Marchand-Pauvert">V. Marchand-Pauvert</name>
<affiliation wicri:level="3"><nlm:affiliation>UPMC Université de Paris 06, ER 6, F-75005 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>UPMC Université de Paris 06, ER 6, F-75005 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gerdelat Mas, A" sort="Gerdelat Mas, A" uniqKey="Gerdelat Mas A" first="A" last="Gerdelat-Mas">A. Gerdelat-Mas</name>
</author>
<author><name sortKey="Ory Magne, F" sort="Ory Magne, F" uniqKey="Ory Magne F" first="F" last="Ory-Magne">F. Ory-Magne</name>
</author>
<author><name sortKey="Calvas, F" sort="Calvas, F" uniqKey="Calvas F" first="F" last="Calvas">F. Calvas</name>
</author>
<author><name sortKey="Mazevet, D" sort="Mazevet, D" uniqKey="Mazevet D" first="D" last="Mazevet">D. Mazevet</name>
</author>
<author><name sortKey="Meunier, S" sort="Meunier, S" uniqKey="Meunier S" first="S" last="Meunier">S. Meunier</name>
</author>
<author><name sortKey="Brefel Courbon, C" sort="Brefel Courbon, C" uniqKey="Brefel Courbon C" first="C" last="Brefel-Courbon">C. Brefel-Courbon</name>
</author>
<author><name sortKey="Vidailhet, M" sort="Vidailhet, M" uniqKey="Vidailhet M" first="M" last="Vidailhet">M. Vidailhet</name>
</author>
<author><name sortKey="Simonetta Moreau, M" sort="Simonetta Moreau, M" uniqKey="Simonetta Moreau M" first="M" last="Simonetta-Moreau">M. Simonetta-Moreau</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:20943434</idno>
<idno type="pmid">20943434</idno>
<idno type="doi">10.1016/j.clinph.2010.08.015</idno>
<idno type="wicri:Area/PubMed/Corpus">000977</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000977</idno>
<idno type="wicri:Area/PubMed/Curation">000937</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000937</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000937</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000937</idno>
<idno type="wicri:Area/Ncbi/Merge">000C31</idno>
<idno type="wicri:Area/Ncbi/Curation">000C31</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000C31</idno>
<idno type="wicri:Area/Main/Merge">001691</idno>
<idno type="wicri:Area/Main/Curation">001610</idno>
<idno type="wicri:Area/Main/Exploration">001610</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease.</title>
<author><name sortKey="Marchand Pauvert, V" sort="Marchand Pauvert, V" uniqKey="Marchand Pauvert V" first="V" last="Marchand-Pauvert">V. Marchand-Pauvert</name>
<affiliation wicri:level="3"><nlm:affiliation>UPMC Université de Paris 06, ER 6, F-75005 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>UPMC Université de Paris 06, ER 6, F-75005 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gerdelat Mas, A" sort="Gerdelat Mas, A" uniqKey="Gerdelat Mas A" first="A" last="Gerdelat-Mas">A. Gerdelat-Mas</name>
</author>
<author><name sortKey="Ory Magne, F" sort="Ory Magne, F" uniqKey="Ory Magne F" first="F" last="Ory-Magne">F. Ory-Magne</name>
</author>
<author><name sortKey="Calvas, F" sort="Calvas, F" uniqKey="Calvas F" first="F" last="Calvas">F. Calvas</name>
</author>
<author><name sortKey="Mazevet, D" sort="Mazevet, D" uniqKey="Mazevet D" first="D" last="Mazevet">D. Mazevet</name>
</author>
<author><name sortKey="Meunier, S" sort="Meunier, S" uniqKey="Meunier S" first="S" last="Meunier">S. Meunier</name>
</author>
<author><name sortKey="Brefel Courbon, C" sort="Brefel Courbon, C" uniqKey="Brefel Courbon C" first="C" last="Brefel-Courbon">C. Brefel-Courbon</name>
</author>
<author><name sortKey="Vidailhet, M" sort="Vidailhet, M" uniqKey="Vidailhet M" first="M" last="Vidailhet">M. Vidailhet</name>
</author>
<author><name sortKey="Simonetta Moreau, M" sort="Simonetta Moreau, M" uniqKey="Simonetta Moreau M" first="M" last="Simonetta-Moreau">M. Simonetta-Moreau</name>
</author>
</analytic>
<series><title level="j">Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology</title>
<idno type="eISSN">1872-8952</idno>
<imprint><date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Analysis of Variance</term>
<term>Antiparkinson Agents (pharmacology)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Deep Brain Stimulation</term>
<term>Electromyography</term>
<term>Female</term>
<term>Humans</term>
<term>Levodopa (pharmacology)</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Muscle Rigidity (therapy)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson Disease (therapy)</term>
<term>Reflex (drug effects)</term>
<term>Reflex (physiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Reflex</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Reflex</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Muscle Rigidity</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Analysis of Variance</term>
<term>Deep Brain Stimulation</term>
<term>Electromyography</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To investigate the contribution of group II spinal pathways in Parkinsonian upper limb rigidity and the modulation of spinal excitability of group I and group II pathways by L-DOPA and subthalamic nucleus-high-frequency stimulation (STN-HFS).</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Île-de-France</li>
</region>
<settlement><li>Paris</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Brefel Courbon, C" sort="Brefel Courbon, C" uniqKey="Brefel Courbon C" first="C" last="Brefel-Courbon">C. Brefel-Courbon</name>
<name sortKey="Calvas, F" sort="Calvas, F" uniqKey="Calvas F" first="F" last="Calvas">F. Calvas</name>
<name sortKey="Gerdelat Mas, A" sort="Gerdelat Mas, A" uniqKey="Gerdelat Mas A" first="A" last="Gerdelat-Mas">A. Gerdelat-Mas</name>
<name sortKey="Mazevet, D" sort="Mazevet, D" uniqKey="Mazevet D" first="D" last="Mazevet">D. Mazevet</name>
<name sortKey="Meunier, S" sort="Meunier, S" uniqKey="Meunier S" first="S" last="Meunier">S. Meunier</name>
<name sortKey="Ory Magne, F" sort="Ory Magne, F" uniqKey="Ory Magne F" first="F" last="Ory-Magne">F. Ory-Magne</name>
<name sortKey="Simonetta Moreau, M" sort="Simonetta Moreau, M" uniqKey="Simonetta Moreau M" first="M" last="Simonetta-Moreau">M. Simonetta-Moreau</name>
<name sortKey="Vidailhet, M" sort="Vidailhet, M" uniqKey="Vidailhet M" first="M" last="Vidailhet">M. Vidailhet</name>
</noCountry>
<country name="France"><region name="Île-de-France"><name sortKey="Marchand Pauvert, V" sort="Marchand Pauvert, V" uniqKey="Marchand Pauvert V" first="V" last="Marchand-Pauvert">V. Marchand-Pauvert</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001610 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001610 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:20943434 |texte= Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:20943434" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonFranceV1
![]() | This area was generated with Dilib version V0.6.29. | ![]() |